The bi-partite letter outlining the changes to the shingles vaccine programme from 1 September 2023 has been published. The programme changes include expanding eligible cohorts to younger age groups so individuals, particularly those with a weakened immune system, can be protected at an earlier age. The vaccine that is used in the programme is also changing with all newly eligible individuals to be offered two doses of the non-live Shingrix vaccine.
